Triglyceride-glucose index for insulin resistance in prediabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a simple test that may help spot insulin resistance early in people with chronic kidney disease who are prediabetic. If the test works, it could lead to earlier steps to protect their health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic kidney disease (CKD stages 2 to 5) or no kidney problems at all
- You do not have diabetes yet (but you may be prediabetic)
- You are not taking steroids or medicines that affect blood sugar or cholesterol
- You are not pregnant, do not have an active infection, and have not had cancer within the last few years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called IGT-303 in people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and helpful for slowing kidney damage.
This study looks at using a urine test to help diagnose and monitor chronic kidney disease (CKD), a condition where your kidneys slowly lose function over time. The study also checks how well a type of medicine called SGLT2 inhibitors (often used for diabetes) actually works in real life for people with CKD. If you have CKD, this research could help improve monitoring and treatment decisions.
This trial studies whether a simple blood test called the triglyceride glucose index can help doctors understand heart artery disease in younger patients who do not have diabetes. It may lead to better ways to assess heart risk and guide treatment.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
This study looks at how a simple blood test (triglyceride glucose index) relates to health outcomes in people with type 2 diabetes. It may help doctors better predict risks and tailor treatments.
This study looks at how well a kidney test tool called KidneyIntelX works in real-world care for people with type 2 diabetes and certain stages of kidney disease. It may help doctors use the tool to better understand kidney risk and guide next steps.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.